Group II mGlu receptor antagonist LY341495 enhances the antidepressant-like effects of ketamine in the forced swim test in rats

about

New Treatment Strategies of Depression: Based on Mechanisms Related to Neuroplasticity.Glutamate-Based Drug Discovery for Novel Antidepressants.Beyond Ketamine: New Approaches to the Development of Safer Antidepressants.

P2860

Q38685420-7A50DDD8-2262-439E-AC45-D1E5161F82BC Q38895017-D8B6978A-8066-4D78-AFEE-598813150286 Q47963007-92FDAED7-8BAE-4F85-A0A9-C25ED56A2CCE

P2860

Group II mGlu receptor antagonist LY341495 enhances the antidepressant-like effects of ketamine in the forced swim test in rats

Item

http://www.wikidata.org/entity/Q37067121

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 11 June 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Group II mGlu receptor antagon ...... n the forced swim test in rats

@en

Group II mGlu receptor antagon ...... the forced swim test in rats.

@nl

type

Item

label

Group II mGlu receptor antagon ...... n the forced swim test in rats

@en

Group II mGlu receptor antagon ...... the forced swim test in rats.

@nl

prefLabel

Group II mGlu receptor antagon ...... n the forced swim test in rats

@en

Group II mGlu receptor antagon ...... the forced swim test in rats.

@nl

P1476

Group II mGlu receptor antagon ...... n the forced swim test in rats

@en

P2093

Karolina Podkowa

http://www.w3.org/2001/XMLSchema#string

P2860

mTOR activation is required for the antidepressant effects of mGluR₂/₃ blockade

Involvement of the mammalian target of rapamycin signaling in the antidepressant-like effect of group II metabotropic glutamate receptor antagonists

Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants

Is the forced swimming test a suitable model for revealing antidepressant activity?

Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application

Antidepressant effects of ketamine in depressed patients

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression

mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists

The mood stabilizer lithium potentiates the antidepressant-like effects and ameliorates oxidative stress induced by acute ketamine in a mouse model of stress

On the mechanism of the antidepressant-like action of group II mGlu receptor antagonist, MGS0039.

P2888

s00213-016-4325-7

P304

2901-2914

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00213-016-4325-7

http://www.w3.org/2001/XMLSchema#string

P433

15-16

http://www.w3.org/2001/XMLSchema#string

P478

233

http://www.w3.org/2001/XMLSchema#string

P50

Andrzej Pilc

Agnieszka Pałucha-Poniewiera

Piotr Brański

Bartłomiej Pochwat

P577

2016-06-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27286960

http://www.w3.org/2001/XMLSchema#string

P932

4933730

http://www.w3.org/2001/XMLSchema#string

Group II mGlu receptor antagonist LY341495 enhances the antidepressant-like effects of ketamine in the forced swim test in rats

about

P2860

P2860

Group II mGlu receptor antagonist LY341495 enhances the antidepressant-like effects of ketamine in the forced swim test in rats

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P932